IMPORTANCE Bicuspid aortic valve (BAV) is considered an autosomal dominant condition, which is commonly associated with thoracic aortic aneurysm. Both conditions pose the risk of valvular and aortic complications not only for affected patients but also for genetically related persons as well. The genetic underpinnings of these disease processes, which are in various stages of elucidation, have implications for screening and risk prognostication.
Report of Cases

Case 1
A man in his 50s presented with hemianopsia of the left eye. Brain imaging demonstrated multiple small bilateral lesions consistent with embolic infarcts. Further workup included blood cultures, which grew Streptococcus sanguinis, and transesophageal echocardiogram demonstrating a calcified BAV with a leaflet perforation, small perivalvular abscess, and a fistula extending from the right sinus of Valsalva to the right atrium ( Figure 1A ). Computed tomography of the chest demonstrated aneurysms of the aortic root (5.5-cm diameter) and ascending aorta (5-cm diameter) (Figure 2 ). At operation, the valve was confirmed to be bicuspid, with fusion of the left and right cusps. The fistula arose from the left ventricular outflow tract rather than the right atrium, as suggested on the preoperative echocardiogram. The patient underwent autologous pericardial patch repair of the fistula and replacement of the aortic valve, aortic root, and ascending aorta (Figure 2 ).
Key Points
Question Can genetic testing in monozoygotic twins with discordant aortic valve morphology (ie, bicuspid and tricuspid aortic valves) contribute to our knowledge of the genetic mechanism of bicuspid aortic valve?
Findings Whole-exome sequencing from one pair of monozygotic twins and targeted gene testing of a second pair of monozygotic twins identified no genetic alterations.
Meaning In addition to gene inheritance, epigenetic effects, somatic mutations, and environmental factors may play a more important role than previously suspected, which may limit the usefulness of genetic screening in risk stratification. Family history included 3 relatives who had undergone aortic aneurysm repair and with no known history of BAVs. Transthoracic echocardiogram of his asymptomatic twin brother ( Figure 1B ) demonstrated a noncalcified trileaflet aortic valve and mild dilation of the aortic root (4.3-cm diameter) and ascending aorta (4.2-cm diameter). Because the twins were thought to be identical but their aortic valves clearly had different structures, zygosity was questioned. Genetic testing with polymerase chain reaction followed by capillary electrophoresis of 15 autosomal short tandem repeat markers and 1 sex marker showed greater than 99% chance of monozygosity (ARUP Laboratories). Whole-exome sequencing was performed. No pathogenic sequence changes were identified in either twin.
Case 2
A man in his 50s underwent bioprosthetic aortic valve replacement for symptomatic severe aortic stenosis with normal ascending aortic dimension (2.5 cm) ( Figure 1C ). At operation, he was found to have a BAV with heavily calcified, dystrophic leaflets and fusion of the left and right cusps. Family history was unremarkable for BAV or aortopathy. Four months previously, his twin brother had undergone transthoracic echocardiography for a syncopal episode. This demonstrated a trileaflet aortic valve without calcification or stenosis ( Figure 1D ). Again, zygosity was queried with genetic testing, which showed greater than 99% chance of monozygosity (ARUP Laboratories). Targeted exon regions from 25 genes that have been implicated in BAV and/or thoracic aortopathy (ACTA2, CBS, COL3A1, COL5A1, COL5A2, FBN1, FBN 2, GATA5, GATA6, HOXA1, KCNJ2, MAT2A, MED12, MYH11, MYLK, NOTCH1, PRKG1, SKI, SLC2A10, SMAD3, SMAD4, SMAD6, TGFB2, TGFBR1, and TGFBR2) were sequenced, mapped, and analyzed. The DNA sample from the twin with the bicuspid valve was compared with the hg 19 reference sequence (GeneDx), a human genome build published by the University of California, Santa Cruz. No pathogenic sequence alterations were found.
Discussion
Bicuspid aortic valve is the most common congenital heart anomaly, with a prevalence of 0.5% to 2% in the population, based on autopsy and echocardiographic studies. Prospectively studied first-degree relatives showed an incidence of 9.1%, and authors have suggested an autosomal dominant pattern with reduced penetrance.
2 Other studies using statistical modeling techniques have shown a high heritability, also consistent with an almost entirely genetic determination of BAV. Bicuspid aortic valve is also a well-known finding in females with the chromosomal condition Turner syndrome. In a small number of nonsyndromic, autosomal dominant human pedigrees, NOTCH1 mutations have been implicated. In mouse models, targeted deletion of Gata5 leads to partially penetrant BAV with fusion of the right and noncoronary leaflets. 3 Recently, nonsynonymous variation within GATA5 transcriptional activation domains were reported in 4 sporadic cases of patients with a BAV 4 but not confirmed in another study of familial BAV. 5 Animal models have identified other potential gene candidates yet to be confirmed in human genetic studies, including eNOS (nos3), Nkx2-5, and Hoxa1.
3
The association between BAV and TAA continues to be debated. Eleven of 12 genes identified in syndromic and nonsyndromic thoracic aortic disease are transmitted in an autosomal dominant pattern.
6 Plasma and aortic tissue specimens of patients undergoing aortic aneurysm resection have shown differential profiles of matrix metalloproteinases, tissue inhibitors, and microRNA expression levels in patients with a BAV vs trileaflet aortic valves. 7, 8 Although these studies downplay, if not outright negate, the contribution of hemodynamic factors, recent cardiovascular magnetic resonance studies have identified abnormal flow patterns in the proximal aorta in patients with a BAV that are associated with increases in aortic wall shear stress and aortic dilation that differ according to the pattern of cusp fusion.
9
It is noteworthy that the twin with the trileaflet aortic valve in case 1 had aortic ectasia (4.3 cm). Loscalzo et al 10 prospectively evaluated family members of 13 individuals with both BAVs and TAAs, finding that all families had at least 1 member with TAA alone, 35% had a BAV and TAA or TAA, and 85% had some form of aortic dilation above the sinotubular junction. The authors concluded that BAV and TAA were independent manifestations of a single gene defect. 10 Others suggest distinct genetic etiologies for BAV and TAA. 11 There is growing evidence that genes typically associated with either BAV, TAA, or syndromic conditions may be implicated in nonsyndromic and/or a concomitant BAV and TAA phenotype (Table) . For example, variants in FBN1, which is associated with Marfan syndrome, have been reported in patients with sporadic TAA and thoracic aortic dissection without a BAV 13,14 as well as in patients with a BAV with concomitant aortic root aneurysms 19 without other phenotypic features of Marfan syndrome. However, in a large cohort of patients with FBN1 mutations, all patients with a BAV and TAA met international criteria for Marfan syndrome.
21
TGFBR2, another gene associated with syndromic (LoeysDietz syndrome) and nonsyndromic (familial) TAA and dissection, was described in 2 first-degree relatives without features of Loeys-Dietz syndrome who underwent surgery for BAV and TAA. 20 In a large cohort of patients with TGFBR2 mutations, of which only 10% had Marfan syndrome, all 7% of those with a BAV also had TAA and moderated skeletal features. Mutations in the 2 genes with known associations with BAV in humans have been described in concomitant BAV and TAA. 17 Four NOTCH1 variants were identified in 10.4% of patients with a BAV and TAA compared with 2.1% of control patients, and 3 of 4 individuals with GATA5 mutations with BAV had some degree of aortic dilation, with 2 presenting concurrently and 1 undergoing surgery 30 years after aortic valve replacement. 17 Despite advances in our contemporary understanding of BAV and its heterogeneous presentations, major gaps in both basic and clinical research persist, and the prospect of registry data holds the greatest promise as called for by the International Bicuspid Aortic Valve Consortium. 23 A link between congenital heart defects and twin gestation has been postulated. Among 41 525 twins in the Danish Registry of Twins, the incidence of congenital heart disease was 63% higher compared with singletons. 24 The first reported case of BAV in twins in 1987 25 followed an earlier report of 6 patients with congenital aortic stenosis whose twin sibling had normal aortic valves, 26 but none of these twin pairs were monozygotic (ie, identical twins). Zafar and Roberts 27 reported brothers with BAVs, one with coarctation and a normal aortic valve and the other with no coarctation but severe aortic stenosis. While reports of monozygotic twins with the same BAV phenotype have been published, 28, 29 we are aware of only 1 report of monozygotic twins with discordant valve morphology, 30 in which identical (and presumed monozygotic) twin brothers each presented at age 62 years with symptomatic aortic stenosis. At operation, one had a calcified BAV and the other a calcified trileaflet valve. However, valve morphology was based on retrospective review of the surgeons' operative reports, with no objective proof of monozygosity. Our report objectively documents discordant valve morphology in monozygotic twins in whom neither calcification nor infective endocarditis had progressed to the point of obscuring the native valve morphology. Further, the trileaflet valves had not calcified to the point that congenital commissural fusion could not be differentiated from advanced calcification of a commissure on echocardiogram. In the first case, mild aortic dilation may be a phenotypic variation of the BAV and TAA syndrome. Phenotypic differences in monozygotic twins may be due to epigenetic effects, somatic mutations, and environmental factors. 31 Whether similar effects, including in utero events, could explain the phenotypic difference in valve morphology of these 4 patients remains unclear.
Conclusions
These 2 cases highlight the gap in knowledge of the genetic underpinnings of BAV. Genetic testing in 2 pairs of monozygotic twins with discordant phenotypes suggests that in addition to gene inheritance, epigenetic effects, somatic mutations, and environmental factors may play a more important role than previously suspected. This may limit the usefulness of genetic screening in risk stratification. Because understanding of the molecular mechanisms of thoracic aortic disease has outpaced that of BAV, these cases highlight the need for ongoing investigation of the pathogenesis of BAV and its associated syndromes. 
TGFBR2
Single-nucleotide substitution in nonsyndromic BAV and proximal TAA 11, 20 ; in a group with TGFBR2 mutations, all patients with a BAV also had TAA and moderated skeletal features 21 
MAT2A
18 Individuals with MAT2A rare variant; 8 diagnosed with TAA and 4 diagnosed with a BAV Abbreviations: AS, aortic stenosis; BAV, bicuspid aortic valve; MFS, Marfan syndrome; TAA, thoracic aortic aneurysm; TAAD, thoracic aortic aneurysm and dissection.
